Navigation Links
AstraZeneca Donates $3.8 million in Medicines for U.S. Free Clinics
Date:1/24/2012

STAMFORD, Conn., Jan. 24, 2012 /PRNewswire-USNewswire/ -- AstraZeneca, the global biopharmaceutical company, has donated $3.8 million worth of prescription medicines to AmeriCares for chronically ill Americans who rely on safety net clinics for their medical care. The donation is one of the largest AmeriCares received in the past year for its domestic aid deliveries.

AmeriCares is delivering the medicines to free clinics and community health centers through its U.S. Medical Assistance Program, which provides free medicines and medical supplies to 400 health care facilities serving the poor and uninsured across the United States. The AstraZeneca products are expected to benefit patients of about 100 clinics in 28 states.

"The medicines donated by AstraZeneca are among the most frequently requested products by our partner clinics," said Morgan White, manager of AmeriCares U.S. Medical Assistance Program. "Thanks to our partnership with AstraZeneca, we are helping the most vulnerable Americans."

Among the clinics receiving AstraZeneca products are:

  • The Way Free Medical Clinic in Florida, where patients have been hard hit by the collapse of the housing market.
  • Traverse Health Clinic in Michigan, where the unemployment rate is one of the highest in the nation.
  • Sacred Heart Community Clinic in Texas, where 25 percent of state residents are uninsured – the highest rate in the country.

Christy Fitzgerald, executive director of The Way Free Medical Clinic in Green Cove Springs, Fla., which received nearly $50,000 worth of AstraZeneca medicines, said the donation has greatly helped patients in the construction industry who have lost jobs or had their hours cut and can no longer afford health insurance. The asthma medicines have been particularly beneficial, she said, because they have allowed the clinic to begin treating patients on the spot.

"Donations like this one are critical because we could never afford to purchase these medicines for our patients," Fitzgerald said.

This is the third consecutive year AstraZeneca has supported AmeriCares aid deliveries in the U.S. with a major donation. The company also supports AmeriCares global disaster response work and aid deliveries in the developing world with product donations. Since 2003, AstraZeneca has donated essential medicines to AmeriCares valued at more than $63 million.

About AmeriCares
AmeriCares is a nonprofit global health and disaster relief organization which delivers medicines, medical supplies and aid to people in need around the world and across the United States. Since it was established in 1982, AmeriCares has distributed more than $10 billion in humanitarian aid to 164 countries. For more information, visit www.AmeriCares.org

CONTACT:
Donna Porstner: Office (203) 658-9579
Cell (516) 607-1180
dporstner@AmeriCares.org


'/>"/>
SOURCE AmeriCares
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
2. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
3. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
4. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
5. AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication
6. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
7. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
8. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
9. AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
10. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
11. AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
(Date:6/26/2016)... California (PRWEB) , ... June 26, 2016 , ... Pixel ... Cut Pro X. , "Film editors can give their videos a whole new perspective ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):